(Q46397663)

21 December 2017

title

Role of kallistatin in prevention of cardiac remodeling after chronic myocardial infarction (English)

1 reference

21 December 2017

main subject

myocardial infarction

1 reference

Lin Gao

1

1 reference

21 December 2017

Hang Yin

2

1 reference

21 December 2017

Robert S Smith

3

1 reference

21 December 2017

Lee Chao

4

1 reference

21 December 2017

Julie Chao

5

1 reference

21 December 2017

publication date

1 September 2008

1 reference

21 December 2017

published in

Laboratory Investigation

1 reference

21 December 2017

volume

88

1 reference

21 December 2017

issue

11

1 reference

21 December 2017

page(s)

1157-1166

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1038/labinvest.2008.85

exact match

0 references

cites work

NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Oxidant signaling in vascular cell growth, death, and survival : a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Role of oxidative stress in cardiac hypertrophy and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

The acute phase protein alpha2-macroglobulin induces rat ventricular cardiomyocyte hypertrophy via ERK1,2 and PI3-kinase/Akt pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Modulation of fibroblast proliferation by oxygen free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Involvement of UVB-induced reactive oxygen species in TGF-beta biosynthesis and activation in keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Kallistatin is a potent new vasodilator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Kallistatin is a new inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

A fluorometric assay for the measurement of nitrite in biological samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Structural elements of kallistatin required for inhibition of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

H(2)O(2)-induced O(2) production by a non-phagocytic NAD(P)H oxidase causes oxidant injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Oxidative stress-induced signal transduction pathways in cardiac myocytes: involvement of ROS in heart diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

The role of TGF-beta signaling in myocardial infarction and cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Induction of oxidative stress and inhibition of plasminogen activator inhibitor-1 production in endothelial cells following exposure to organic extracts of diesel exhaust particles and urban fine particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Redox-mediated activation of latent transforming growth factor-beta 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Taurine inhibits oxidative damage and prevents fibrosis in carbon tetrachloride-induced hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Nitrosative stress and pharmacological modulation of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Mitochondria as targets for nitric oxide-induced protection during simulated ischemia and reoxygenation in isolated neonatal cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Non-enzymatic nitric oxide synthesis in biological systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

The nitric oxide hypothesis of late preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

7 January 2021

Carbon monoxide and bilirubin from heme oxygenase-1 suppresses reactive oxygen species generation and plasminogen activator inhibitor-1 induction

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

7 January 2021

Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

7 January 2021

The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

7 January 2021

Contribution of endogenous nitric oxide to basal vasomotor tone of peripheral vessels and plasma B-type natriuretic peptide levels in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.85

7 January 2021

10.1038/LABINVEST.2008.85

Identifiers

DOI

1 reference

21 December 2017

release_rhvbxlbg4vb5dd7dsnu6mqniyq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rhvbxlbg4vb5dd7dsnu6mqniyq

24 November 2022

mapped directly with Wikidata item

PubMed ID

18762777

1 reference

21 December 2017